ITMR
COM:ITAMAR-MEDICAL
Itamar Medical
- Stock
Last Close
30.87
01/01 00:00
Volume Today
1.02M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 1.26M - | 1.51M 19.43% | 1.68M 11.69% | 2.02M 20.21% | 2.25M 11.15% | 2.80M 24.54% | 5.26M 88.05% | |
average payables | 893.50K - | 1.07M 19.64% | 1.19M 11.27% | 1.29M 8.70% | 1.39M 7.46% | 1.77M 27.56% | 3.22M 81.83% | |
average receivables | 2.95M - | 3.85M 30.56% | 4.55M 18.09% | 5.40M 18.73% | 6.33M 17.05% | 7.98M 26.21% | 9.37M 17.38% | |
book value per share | -0.82 - | 2.65 423.95% | 0.60 77.41% | 0.16 73.88% | 0.76 385.69% | 1.50 97.83% | 3.11 106.96% | |
capex per share | -0.03 - | -0.09 153.62% | -0.05 40.85% | -0.03 35.33% | -0.04 4.73% | -0.05 40.10% | -0.16 226.43% | |
capex to depreciation | -0.62 - | -1.53 145.62% | -1.05 31.54% | -0.58 44.53% | -0.64 10.83% | -0.43 34.05% | -1.23 188.60% | |
capex to operating cash flow | 0.04 - | 0.07 75.88% | 0.04 34.42% | 0.05 11.86% | 0.08 66.74% | 0.25 - | ||
capex to revenue | -0.01 - | -0.03 171.27% | -0.02 26.21% | -0.01 42.05% | -0.01 10.37% | -0.02 36.55% | -0.05 210.55% | |
cash per share | 3.15 - | 5.59 77.63% | 2.99 46.55% | 1.23 58.87% | 0.74 40.17% | 1.36 85.45% | 2.86 110.15% | |
days of inventory on hand | 108.94 - | 131.04 20.29% | 130.78 0.20% | 164.91 26.10% | 142.47 13.61% | 175.76 23.37% | 212.19 20.73% | |
days payables outstanding | 82.39 - | 87.50 6.20% | 97.06 10.93% | 92.09 5.12% | 96.70 5.01% | 105.99 9.60% | 130.86 23.47% | |
days sales outstanding | 79.90 - | 89.50 12.02% | 98.59 10.16% | 102.72 4.19% | 102.97 0.24% | 106.74 3.66% | 85.37 20.02% | |
debt to assets | 1.19 - | 0.61 48.71% | 0.85 39.20% | 0.94 9.70% | 0.64 31.96% | 0.50 21.71% | 0.33 34.07% | |
debt to equity | -6.15 - | 1.58 125.70% | 5.78 265.89% | 14.45 149.92% | 1.75 87.89% | 0.99 43.27% | 0.49 50.73% | |
dividend yield | ||||||||
earnings yield | -0.05 - | -0.03 37.45% | -0.14 368.29% | -0.05 63.41% | -0.02 67.38% | -0.04 125.55% | -0.04 7.75% | |
enterprise value | 75.09M - | 58.61M 21.94% | 99.45M 69.68% | 108.70M 9.30% | 104.17M 4.16% | 127.59M 22.48% | 271.34M 112.67% | |
enterprise value over ebitda | -239.89 - | 24.00 110.00% | -10.78 144.90% | -388.20 3,502.13% | -315.67 18.68% | -34.86 88.96% | -32.18 7.69% | |
ev to operating cash flow | -13.80 - | -6.81 50.65% | -9.36 37.44% | -17.58 87.94% | -26.83 52.58% | -30.77 - | ||
ev to sales | 4.58 - | 3.49 23.89% | 5.39 54.65% | 5.25 2.64% | 4.31 17.98% | 4.08 5.22% | 6.61 62.00% | |
free cash flow per share | -0.97 - | -1.43 48.12% | -1.27 11.70% | -0.74 41.91% | -0.48 35.27% | -0.80 - | ||
free cash flow yield | -0.08 - | -0.12 48.12% | -0.11 11.70% | -0.06 41.91% | -0.04 35.27% | -0.04 - | ||
graham net net | -1.30 - | 2.01 253.93% | 0.05 97.37% | -0.41 873.36% | 0.11 127.97% | 0.64 463.04% | 2.12 230.93% | |
graham number | 3.22 - | 4.58 42.34% | 4.71 2.85% | 1.46 69.09% | 1.83 25.86% | 4.01 118.76% | 7.44 85.50% | |
income quality | 1.66 - | 3.83 130.55% | 0.74 80.74% | 1.17 58.01% | 2.25 92.58% | 0.81 - | ||
intangibles to total assets | 0.01 - | 0.01 22.85% | 0.01 11.74% | 0.01 80.07% | 0.02 24.46% | 0.50 2,975.22% | 0.02 96.76% | |
interest coverage | -1.44 - | -1.30 9.18% | -2.17 66.57% | -1.32 39.18% | -3.93 197.56% | -17.23 338.40% | -18.41 6.81% | |
interest debt per share | 2.93 - | 2.99 1.92% | 2.56 14.28% | 1.72 32.89% | 0.66 61.69% | 0.56 15.40% | 0.47 15.04% | |
inventory turnover | 3.35 - | 2.79 16.87% | 2.79 0.20% | 2.21 20.70% | 2.56 15.75% | 2.08 18.94% | 1.72 17.17% | |
invested capital | -3.05 - | 0.88 128.80% | 3.39 286.03% | 7.77 128.82% | 0.75 90.38% | 0.35 52.72% | 0.14 60.66% | |
market cap | 69.94M - | 76.72M 9.70% | 105.02M 36.88% | 105.64M 0.60% | 105.64M 0% | 142.71M 35.08% | 275.02M 92.72% | |
net current asset value | -5.77M - | 14.82M 357.02% | 2.86M 80.72% | -777K 127.20% | 4.57M 688.03% | 11.72M 156.58% | 36.37M 210.25% | |
net debt to ebitda | -16.44 - | -7.42 54.89% | 0.60 108.13% | -10.90 1,907.40% | 4.46 140.88% | 4.13 7.35% | 0.44 89.43% | |
net income per share | -0.56 - | -0.35 37.45% | -1.65 368.29% | -0.60 63.41% | -0.20 67.38% | -0.48 141.91% | -0.79 66.27% | |
operating cash flow per share | -0.93 - | -1.35 44.20% | -1.21 9.80% | -0.70 42.19% | -0.44 37.19% | -0.64 - | ||
payables turnover | 4.43 - | 4.17 5.84% | 3.76 9.85% | 3.96 5.40% | 3.77 4.77% | 3.44 8.76% | 2.79 19.01% | |
receivables turnover | 4.57 - | 4.08 10.73% | 3.70 9.23% | 3.55 4.02% | 3.54 0.24% | 3.42 3.53% | 4.28 25.02% | |
research and ddevelopement to revenue | 0.12 - | 0.17 36.85% | 0.17 3.83% | 0.20 14.05% | 0.15 24.60% | 0.14 3.85% | 0.15 1.15% | |
return on tangible assets | -0.13 - | -0.05 61.54% | -0.41 689.33% | -0.25 38.15% | -0.10 62.15% | -0.32 230.89% | -0.17 45.17% | |
revenue per share | 2.81 - | 2.63 6.50% | 2.11 19.84% | 2.35 11.60% | 2.75 16.85% | 2.82 2.60% | 2.96 5.11% | |
roe | 0.69 - | -0.13 119.31% | -2.75 1,973.15% | -3.85 40.08% | -0.26 93.28% | -0.32 22.28% | -0.25 19.66% | |
roic | -0.81 - | 0.25 130.82% | 0.81 225.19% | -1.26 255.39% | -0.85 31.98% | -5.19 507.53% | -0.26 95.01% | |
sales general and administrative to revenue | 0.28 - | 0.26 9.53% | 0.29 13.75% | 0.25 12.35% | 0.22 14.92% | 0.20 6.29% | 0.21 1.94% | |
shareholders equity per share | -0.82 - | 2.65 423.95% | 0.60 77.41% | 0.16 73.88% | 0.76 385.69% | 1.50 97.83% | 3.11 106.96% | |
stock based compensation to revenue | 0.09 - | 0.03 71.71% | 0.10 278.21% | 0.06 35.10% | 0.04 32.47% | 0.04 - | ||
tangible asset value | -4.98M - | 16.67M 434.97% | 4.98M 70.10% | 1.10M 77.93% | 6.39M 480.91% | 118K 98.15% | 42.03M 35,522.88% | |
tangible book value per share | -0.85 - | 2.61 405.35% | 0.57 78.15% | 0.12 78.06% | 0.73 480.91% | 0.01 98.53% | 3.04 28,423.48% | |
working capital | 18.86M - | 36.99M 96.16% | 18.84M 49.06% | 3.36M 82.19% | 6.22M 85.40% | 14.95M 140.29% | 39.45M 163.84% |
All numbers in USD (except ratios and percentages)